We are live on
!
Find out more
SAM
Symphony Asset Management Portfolio holdings
AUM
$309M
1-Year Est. Return
9.39%
This Fund
S&P 500
This Quarter
Est. Return
+1.06%
1 Year Est. Return
+9.39%
3 Year Est. Return
+21.56%
5 Year Est. Return
+39.45%
10 Year Est. Return
–
AUM
$802M
AUM Growth
-$58.4M
(-6.8%)
Cap. Flow
-$269M
Cap. Flow
% of AUM
-33.59%
Top 10 Holdings %
Top 10 Hldgs %
20.2%
Holding
527
New
56
Increased
129
Reduced
159
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.77M |
| 2 |
Teleflex
TFX
|
+$2.97M |
| 3 |
AbbVie
ABBV
|
+$2.97M |
| 4 |
JAH
JARDEN CORPORATION
JAH
|
+$2.23M |
| 5 |
UnitedHealth
UNH
|
+$2.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$9.16M |
| 2 |
Walt Disney
DIS
|
+$4.75M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$4.4M |
| 4 |
Ameriprise Financial
AMP
|
+$3.87M |
| 5 |
Booking.com
BKNG
|
+$3.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.74% |
| 2 | Technology | 8.53% |
| 3 | Financials | 7.96% |
| 4 | Industrials | 7.73% |
| 5 | Consumer Discretionary | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.8B
| $269K | 0.03% |
2,165
-3,341
| -61% | -$403K |
|
327
Zebra Technologies
ZBRA
$12.4B
| $267K | 0.03% |
+2,407
| New | +$250K |
|
|
AJRD
328
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $263K | 0.03% |
12,775
-1,338
| -9% | -$28K |
|
|
PGNX
329
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $260K | 0.03% |
+34,833
| New | +$211K |
|
330
Evertec
EVTC
$1.83B
| $251K | 0.03% |
11,818
-11,871
| -50% | -$261K |
|
331
Casey's General Stores
CASY
$31.9B
| $249K | 0.03% |
2,600
-2,527
| -49% | -$225K |
|
332
Essent Group
ESNT
$6.06B
| $247K | 0.03% |
9,035
-8,843
| -49% | -$227K |
|
|
NEWP
333
DELISTED
NEWPORT CORP
NEWP
| $247K | 0.03% |
13,004
-13,113
| -50% | -$254K |
|
334
Electronic Arts
EA
$52.4B
| $244K | 0.03% |
+3,664
| New | +$225K |
|
|
ABGB
335
DELISTED
Abengoa SA Class B
ABGB
| $242K | 0.03% |
15,182
-2,119
| -12% | -$35.8K |
|
336
Marriott International
MAR
$98.7B
| $235K | 0.03% |
3,153
-22
| -0.7% | -$1.74K |
|
337
Axcelis
ACLS
$4.12B
| $232K | 0.03% |
19,619
-9,342
| -32% | -$108K |
|
338
TD Synnex
SNX
$19.4B
| $232K | 0.03% |
6,342
-11,392
| -64% | -$452K |
|
339
Cheniere Energy
LNG
$56.5B
| $231K | 0.03% |
3,337
-8,188
| -71% | -$614K |
|
340
Radware
RDWR
$1.24B
| $230K | 0.03% |
10,365
-10,172
| -50% | -$236K |
|
341
Unitil
UTL
$1,000M
| $225K | 0.03% |
6,832
-3,709
| -35% | -$125K |
|
|
PFC
342
DELISTED
Premier Financial Corp. Common Stock
PFC
| $223K | 0.03% |
11,852
-11,876
| -50% | -$209K |
|
|
NBL
343
DELISTED
Noble Energy, Inc.
NBL
| $222K | 0.03% |
5,197
-12,637
| -71% | -$596K |
|
344
Humana
HUM
$46.7B
| $220K | 0.03% |
1,149
-8
| -0.7% | -$1.49K |
|
345
Park-Ohio Holdings
PKOH
$554M
| $219K | 0.03% |
4,534
-2,805
| -38% | -$138K |
|
346
Clearwater Paper
CLW
$271M
| $215K | 0.03% |
3,755
-3,668
| -49% | -$226K |
|
347
Tandem Diabetes Care
TNDM
$1.17B
| $215K | 0.03% |
+1,979
| New | +$246K |
|
|
KCG
348
DELISTED
KCG Holdings, Inc.
KCG
| $213K | 0.03% |
17,322
-60,762
| -78% | -$791K |
|
349
DexCom
DXCM
$27.6B
| $210K | 0.03% |
10,508
-10,624
| -50% | -$187K |
|
350
Nucor
NUE
$56.4B
| $205K | 0.03% |
4,652
+115
| +3% | +$5.52K |
|
Similar funds
LWM
FCI
TAM
BHG
NIT
ACMV
TL
RCM
Symphony Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Symphony Asset Management held 527 positions worth $802M, down 6.8% from $860M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Symphony Asset Management withdrew a net $269M in Q2 2015, closing 115 positions and reducing 159 holdings. Its most notable exit was TRIBUNE MEDIA COMPANY CLASS A, an estimated $9.16M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 8.3% a quarter earlier, followed by Technology and Financials.
Against the trend, Symphony Asset Management opened a new position in Teleflex worth $3.17M.
- Symphony Asset Management's largest Q2 2015 buy was Teleflex: 23,379 shares worth $3.17M.
- Symphony Asset Management added most to Allergan plc in Q2 2015, an estimated $6.77M increase.
- Symphony Asset Management's biggest Q2 2015 reduction was The WhiteWave Foods Company, cutting an estimated $2.47M.
- Symphony Asset Management fully exited TRIBUNE MEDIA COMPANY CLASS A in Q2 2015, selling an estimated $9.16M.
- Symphony Asset Management's ten largest holdings make up 20% of its $802M portfolio in Q2 2015.
- Symphony Asset Management opened 56 new positions and closed 115 in Q2 2015.
- Symphony Asset Management's portfolio value fell 6.8% quarter-over-quarter to $802M.
Based on Symphony Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.